• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer.

作者信息

Beyan Cengiz, Beyan Esin

机构信息

Ufuk University Faculty of Medicine, Cigdem Mahallesi, 1551. Cadde, Iskent sitesi, No: 7/7, Cankaya, 06520, Ankara, Turkey.

Department of Internal Medicine, University of Health Sciences, Kecioren Training and Research Hospital, Ankara, Turkey.

出版信息

Int J Clin Oncol. 2020 Dec;25(12):2175-2176. doi: 10.1007/s10147-020-01751-5. Epub 2020 Jul 16.

DOI:10.1007/s10147-020-01751-5
PMID:32676835
Abstract
摘要

相似文献

1
Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer.
Int J Clin Oncol. 2020 Dec;25(12):2175-2176. doi: 10.1007/s10147-020-01751-5. Epub 2020 Jul 16.
2
Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020.
Int J Clin Oncol. 2020 Dec;25(12):2177-2178. doi: 10.1007/s10147-020-01815-6. Epub 2020 Oct 26.
3
Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer.血小板体积可预测转移性去势抵抗性前列腺癌的治疗特异性结局。
Int J Clin Oncol. 2020 Sep;25(9):1695-1703. doi: 10.1007/s10147-020-01712-y. Epub 2020 Jun 2.
4
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate.转移性去势抵抗性前列腺癌患者全血 RNA 中的 AR-V7 转录本与醋酸阿比特龙的反应相关。
J Urol. 2017 Jan;197(1):135-142. doi: 10.1016/j.juro.2016.06.094. Epub 2016 Jul 17.
5
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.基于日本前列腺癌标准激素和化疗骨扫描指数队列研究的前列腺癌伴骨转移患者预后分析。
Int J Urol. 2021 Sep;28(9):955-963. doi: 10.1111/iju.14614. Epub 2021 Jun 19.
6
Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo.未经化疗的转移性去势抵抗性前列腺癌且基线前列腺特异性抗原低的男性患者使用恩扎卢胺与安慰剂治疗的临床结局对比。
J Urol. 2017 Dec;198(6):1324-1332. doi: 10.1016/j.juro.2017.07.071. Epub 2017 Jul 20.
7
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.转移性去势抵抗性前列腺癌患者接受醋酸阿比特龙治疗的血液学参数。
Future Oncol. 2019 May;15(13):1469-1479. doi: 10.2217/fon-2018-0635. Epub 2019 Apr 12.
8
Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer.多西他赛在激素敏感性和去势抵抗性转移性前列腺癌之间安全性和疗效的比较评估。
Urol Oncol. 2019 Dec;37(12):999-1005. doi: 10.1016/j.urolonc.2019.07.005. Epub 2019 Jul 31.
9
The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer.多西他赛化疗治疗去势抵抗性前列腺癌的肿瘤学结局和风险分层。
Jpn J Clin Oncol. 2014 Sep;44(9):860-7. doi: 10.1093/jjco/hyu081. Epub 2014 Jun 20.
10
Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer.血小板-淋巴细胞和中性粒细胞-淋巴细胞比值是预测转移性去势抵抗性前列腺癌阿比特龙治疗反应的预后指标，但不是预测指标。
Clin Transl Oncol. 2017 Dec;19(12):1531-1536. doi: 10.1007/s12094-017-1699-x. Epub 2017 Jul 17.

本文引用的文献

1
Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020.
Int J Clin Oncol. 2020 Dec;25(12):2177-2178. doi: 10.1007/s10147-020-01815-6. Epub 2020 Oct 26.